We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
+6.74%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$13B
AUM Growth
+$2.16B
(+20%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
11.39%
Top 10 Holdings %
Top 10 Hldgs %
23.52%
Holding
1,403
New
158
Increased
272
Reduced
367
Closed
584
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$541M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$352M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$180M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$161M |
| 5 |
Humana
HUM
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$230M |
| 2 |
Gilead Sciences
GILD
|
+$154M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$113M |
| 4 |
Micron Technology
MU
|
+$101M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$97.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.71% |
| 2 | Healthcare | 11.57% |
| 3 | Communication Services | 11.06% |
| 4 | Industrials | 10.09% |
| 5 | Technology | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Sunoco
SUN
$14.2B
| $1.83M | 0.01% |
+64,400
| New | +$1.94M |
|
427
Bio-Rad Laboratories Class A
BIO
$8.42B
| $1.82M | 0.01% |
7,638
+1,249
| +20% | +$303K |
|
428
Globe Life
GL
$13.5B
| $1.79M | 0.01% |
19,692
-2,466
| -11% | -$212K |
|
429
Edwards Lifesciences
EW
$47.6B
| $1.77M | 0.01% |
47,139
-52,173
| -53% | -$1.91M |
|
430
Canadian National Railway
CNI
$78.3B
| $1.76M | 0.01% |
21,352
-381
| -2% | -$30.7K |
|
|
GXP
431
DELISTED
Great Plains Energy Incorporated
GXP
| $1.74M | 0.01% |
54,058
-201,627
| -79% | -$6.63M |
|
432
Kinross Gold
KGC
$28.5B
| $1.68M | 0.01% |
389,312
-293,057
| -43% | -$1.22M |
|
|
QUOT
433
DELISTED
Quotient Technology Inc
QUOT
| $1.6M | 0.01% |
136,529
-8,902
| -6% | -$123K |
|
434
American Water Works
AWK
$26.3B
| $1.56M | 0.01% |
17,095
+807
| +5% | +$71.3K |
|
435
News Corp Class A
NWSA
$14.5B
| $1.56M | 0.01% |
96,295
+60,954
| +172% | +$912K |
|
436
Thermo Fisher Scientific
TMO
$211B
| $1.56M | 0.01% |
8,204
-15,293
| -65% | -$2.93M |
|
|
VAR
437
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.55M | 0.01% |
+13,993
| New | +$1.5M |
|
|
XLNX
438
DELISTED
Xilinx Inc
XLNX
| $1.54M | 0.01% |
+22,914
| New | +$1.63M |
|
|
WPZ
439
DELISTED
Williams Partners L.P.
WPZ
| $1.54M | 0.01% |
39,673
+1,826
| +5% | +$68.6K |
|
|
FISV
440
Fiserv Inc
FISV
$27.2B
| $1.53M | 0.01% |
23,306
-63,928
| -73% | -$4.13M |
|
441
Sinclair Inc
SBGI
$974M
| $1.52M | 0.01% |
40,261
+12,407
| +45% | +$411K |
|
442
Royal Bank of Canada
RY
$291B
| $1.52M | 0.01% |
18,564
-8,725
| -32% | -$692K |
|
443
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $1.52M | 0.01% |
13,067
+2,287
| +21% | +$264K |
|
444
Dominion Energy
D
$62.5B
| $1.51M | 0.01% |
+18,634
| New | +$1.51M |
|
445
FMC
FMC
$1.42B
| $1.49M | 0.01% |
+18,177
| New | +$1.46M |
|
446
Nike
NKE
$61.9B
| $1.48M | 0.01% |
23,709
-306,148
| -93% | -$17.6M |
|
447
Booz Allen Hamilton
BAH
$8.7B
| $1.46M | 0.01% |
38,312
+4,771
| +14% | +$180K |
|
448
Globus Medical
GMED
$10.4B
| $1.45M | 0.01% |
+35,276
| New | +$1.23M |
|
449
Crown Castle
CCI
$32.7B
| $1.42M | 0.01% |
12,810
+9,633
| +303% | +$1.04M |
|
450
EOG Resources
EOG
$78B
| $1.41M | 0.01% |
+13,105
| New | +$1.32M |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q4 2017 Portfolio in Review
As of Q4 2017, Natixis held 1,403 positions worth $13B, up 20% from $10.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Natixis deployed $1.48B of net new capital in Q4 2017, opening 158 new positions and adding to 272 existing holdings. Its largest new stake was Humana: 509,381 shares worth $126M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $230M trimmed.
- Natixis's largest Q4 2017 buy was Humana: 509,381 shares worth $126M.
- Natixis added most to Comcast in Q4 2017, an estimated $541M increase.
- Natixis's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $230M.
- Natixis fully exited CR Bard Inc. in Q4 2017, selling an estimated $113M.
- Natixis's ten largest holdings make up 24% of its $13B portfolio in Q4 2017.
- Natixis opened 158 new positions and closed 584 in Q4 2017.
- Natixis's portfolio value rose 20% quarter-over-quarter to $13B.
Based on Natixis's 13F filing for Q4 2017, filed 14 Feb 2018.